Pancreatic Cancer Research

ResearcherNebraska Medical CenterNo recent work listed

Sukhwinder Kaur

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8976-0916; OpenAlex author ID A5101737584. Sources: OpenAlex.

Their work

Papers
25 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
90
Papers, trials and grants by year

2011: 3 papers · 2012: 2 papers · 2013: 2 papers · 2014: 2 papers · 2015: 3 papers · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: 3 papers · 2020: 2 papers · 2021: 1 paper · 2022: 4 papers

Papers 25

  1. Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling. Co-author DOI 10.1016/j.ebiom.2021.103772↗
  2. Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance. Co-author DOI 10.1053/j.gastro.2021.09.017↗
  3. Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft. Co-author DOI 10.21873/invivo.12676↗
  4. Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma. Co-author PMID 35141005↗
  5. Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness. Co-author DOI 10.1158/0008-5472.can-20-1293↗
  6. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Co-author DOI 10.1016/j.bbcan.2019.188318↗
  7. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN. First author DOI 10.1158/1055-9965.epi-20-0161↗
  8. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. Co-author DOI 10.1016/j.ebiom.2019.03.056↗
  9. Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic cancer. Last author DOI 10.1016/j.nano.2018.11.008↗
  10. Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. Co-author DOI 10.1038/s41598-018-36328-w↗
  11. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. Co-author DOI 10.1186/s13046-018-0963-4↗
  12. Biological determinants of radioresistance and their remediation in pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2017.02.003↗
  13. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. Co-author DOI 10.1038/ajg.2016.482↗
  14. Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages. Co-author DOI 10.1038/onc.2014.154↗
  15. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer. Co-author DOI 10.1038/onc.2014.409↗
  16. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Co-author DOI 10.18632/oncotarget.2990↗
  17. Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation. Co-author DOI 10.1038/bjc.2014.385↗
  18. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-2174↗
  19. Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy. Co-author DOI 10.1016/j.canlet.2013.03.017↗
  20. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. Co-author DOI 10.1371/journal.pone.0055171↗
  21. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. Co-author DOI 10.1186/1756-8722-5-68↗
  22. Early diagnosis of pancreatic cancer: challenges and new developments. Co-author DOI 10.2217/bmm.12.69↗
  23. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Co-author DOI 10.1002/cncr.25803↗
  24. Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0023344↗
  25. Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. Co-author DOI 10.3233/cbm-2012-0260↗

Closest collaborators

The 25 strongest of 90 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 25 shared papers, 2011–2022 · strength 1.73
  2. Satyanarayana Rachagani · 12 shared papers, 2011–2022 · strength 0.68
  3. Pranita Atri · 6 shared papers, 2019–2022 · strength 0.67
  4. Maneesh Jain · 12 shared papers, 2011–2022 · strength 0.67
  5. Lynette M. Smith · 9 shared papers, 2011–2022 · strength 0.53
  6. Joseph Carmicheal · 5 shared papers, 2019–2022 · strength 0.48
  7. Koelina Ganguly · 4 shared papers, 2019–2022 · strength 0.43
  8. Kavita B. Mallya · 6 shared papers, 2011–2022 · strength 0.42
  9. Sushil Kumar K · 6 shared papers, 2011–2022 · strength 0.38
  10. Michael J. Baine · 8 shared papers, 2011–2017 · strength 0.31
  11. Randall E. Brand · 5 shared papers, 2011–2020 · strength 0.30
  12. Moorthy Palanimuthu Ponnusamy · 4 shared papers, 2012–2022 · strength 0.29
  13. Michael Anthony Hollingsworth · 4 shared papers, 2014–2022 · strength 0.27
  14. Parthasarathy Seshacharyulu · 4 shared papers, 2012–2022 · strength 0.24
  15. Sanchita Rauth · 2 shared papers, 2021–2022 · strength 0.24
  16. Jesse L. Cox · 2 shared papers, 2021–2022 · strength 0.24
  17. Asish Patel · 3 shared papers, 2017–2020 · strength 0.23
  18. Paul M. Grandgenett · 2 shared papers, 2019–2022 · strength 0.23
  19. Geoffrey A. Talmon · 2 shared papers, 2020–2022 · strength 0.21
  20. Sanjib Chaudhary · 2 shared papers, 2018–2022 · strength 0.20
  21. Ramesh Pothuraju · 2 shared papers, 2018–2021 · strength 0.20
  22. Rahat Jahan · 2 shared papers, 2019–2021 · strength 0.19
  23. Shailender Singh · 3 shared papers, 2013–2020 · strength 0.19
  24. Chi H. Lin · 2 shared papers, 2017–2022 · strength 0.18
  25. Michel M. Ouellette · 2 shared papers, 2017–2022 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.